AT
TEVA icon

Acadia Trust’s Teva Pharmaceuticals TEVA Stock Holding History

Acadia Trust’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-3,766
Closed -$217K – 85
2014
Q4 		$217K Sell
3,766
-1,660
-31% -$92.5K 0.07% 80
2014
Q3 		$291K Sell
5,426
-141,716
-96% -$7.51M 0.11% 71
2014
Q2 		$7.71M Sell
147,142
-11,714
-7% -$599K 2.82% 17
2014
Q1 		$8.39M Buy
158,856
+3,227
+2% +$149K 3.15% 10
2013
Q4 		$6.24M Buy
155,629
+4,000
+3% +$158K 2.46% 24
2013
Q3 		$5.73M Buy
151,629
+16,021
+12% +$625K 2.46% 25
2013
Q2 		$5.32M Buy
+135,608
New +$5.28M 2.36% 30

Other funds holding TEVA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
MIP
Mondrian Investment Partners London, United Kingdom $6.69B AUM
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

Acadia Trust's TEVA Position: Q1 2015 in Review

Acadia Trust sold out of Teva Pharmaceuticals (TEVA) in Q1 2015, closing a stake of 3,766 shares — an estimated $217K sold.

Acadia Trust first reported a position in TEVA in Q2 2013 and held it in 7 quarters. The position peaked at $8.39M in Q1 2014. 821 funds tracked by Wall St. Rank hold TEVA as of Q1 2015.

  • Acadia Trust reported no remaining Teva Pharmaceuticals position as of Q1 2015 after selling out during the quarter.
  • Acadia Trust sold 3,766 Teva Pharmaceuticals shares in Q1 2015, an estimated $217K.
  • Acadia Trust first reported a position in Teva Pharmaceuticals in Q2 2013 and held it in 7 quarters.
  • Acadia Trust's Teva Pharmaceuticals position peaked at $8.39M in Q1 2014.
  • 821 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2015.

Based on Acadia Trust's 13F filing for Q1 2015, filed 11 May 2015.